Home » Blog » Jeanne Davie Vice President, Human Resources

Jeanne Davie Vice President, Human Resources

contact name: Jeanne Davie
contact job function details: hr
contact job function: human_resources

contact job title: Vice President, Human Resources

contact job seniority: vp

contact person city:

contact person state: Shanghai

contact person country: China

contact person zip code: 200131

business name: WuXi AppTec

business domain: wuxiapptec.com

business facebook URL:

business linkedin: http://www.linkedin.com/company/251028

business twitter:

business website: http://www.wuxiapptec.com

cameroon phone number lead 1 million package

business angellist:

business found year: 2000

business city: Shanghai

business zip code: 200131

business state: Shanghai

business country: China

business language: English

business employee: 1556

matthew oxleymanaging director

business category: pharmaceuticals

business specialty: drug discovery, biologics, medical device, bioanalytical, cell & gene therapy, lab testing, genomics, chemistry, toxicology, biological reagents, clinical & regulatory, drug development, api development & manufacturing, pharmaceuticals

business technology: dns_made_easy,outlook,office_365,demandbase,backbone_js_library,omniture_adobe,hubspot,wordpress_org,on24,icims,mobile_friendly,google_font_api,sharethis,google_analytics,facebook_like_button,apache

business description: WuXi AppTec is a leading global contract research outsourcing provider, serving the worldwide pharmaceutical, biotech, and medical device industries. We provide a broad and integrated portfolio of laboratory and manufacturing services throughout the R&D process. Services include: A full range of discovery and development services for pharmaceuticals; development and testing services for biotherapeutics and medical devices; and comprehensive toxicology services as well as manufacturing services for advanced intermediates and active pharmaceutical ingredients (APIs); cell banking services; and cGMP manufacturing for cellular therapeutics and combination/tissue-based products

 

 

Scroll to Top